Cargando…

Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial

OBJECTIVE: To assess whether offering free mailed nicotine replacement therapy (NRT) and telephone counselling to smokers on elective surgery waiting lists increases quitting before surgery. DESIGN, SETTING: Randomised, controlled trial at Frankston Hospital, a public tertiary referral hospital in M...

Descripción completa

Detalles Bibliográficos
Autores principales: Webb, Ashley R, Coward, Lisa, Meanger, Darshana, Leong, Samuel, White, Sarah L, Borland, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314866/
https://www.ncbi.nlm.nih.gov/pubmed/35267206
http://dx.doi.org/10.5694/mja2.51453
_version_ 1784754421308063744
author Webb, Ashley R
Coward, Lisa
Meanger, Darshana
Leong, Samuel
White, Sarah L
Borland, Ron
author_facet Webb, Ashley R
Coward, Lisa
Meanger, Darshana
Leong, Samuel
White, Sarah L
Borland, Ron
author_sort Webb, Ashley R
collection PubMed
description OBJECTIVE: To assess whether offering free mailed nicotine replacement therapy (NRT) and telephone counselling to smokers on elective surgery waiting lists increases quitting before surgery. DESIGN, SETTING: Randomised, controlled trial at Frankston Hospital, a public tertiary referral hospital in Melbourne. PARTICIPANTS: Adult smokers added to elective surgery waiting lists for operations at least ten days in the future, 1 April 2019 ‒ 3 April 2020. INTERVENTION: In addition to normal care, intervention participants received a brochure on the risks of low frequency smoking, an offer of Quitline call‐back registration, and an offer of mailed NRT according to reported daily smoking: 1‒9 cigarettes/day, 2 mg lozenges; 10‒15/day, 7‒14 mg patches [three weeks] and 2 mg lozenges; > 15/day, 7‒21 mg patches [five weeks] and 2 mg lozenges. MAIN OUTCOME MEASURES: Primary outcome: quitting at least 24 hours before surgery, verified by exhaled carbon monoxide testing. Secondary outcomes: quitting at least four weeks before surgery, adverse events, and (for those who had quit before surgery) abstinence three months after surgery. RESULTS: Of 748 eligible participants (control, 363; intervention, 385), 516 (69%) had undergone elective surgery when the trial was terminated early (for COVID‐19‐related reasons) (intervention group, 274; control group, 242). 122 of the 385 intervention participants (32%) had accepted the offer of cessation support. The proportions of intervention participants who quit at least 24 hours before surgery (18% v 9%; odds ratio [OR], 1.97; 95% CI, 1.22‒3.15) or at least four weeks before surgery (9% v 4%; OR, 2.20; 95% CI, 1.08–4.50) were larger than for the control group. Three months after surgery, 27 of 58 intervention (47%) and 12 of 25 control participants (48%) who quit before surgery reported not smoking in the preceding seven days. No major adverse events were reported. CONCLUSION: Uptake of free mailed NRT and Quitline support by smokers on elective surgery waiting lists was good, and offering additional support was associated with higher proportions of smokers quitting before surgery. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12619000032156 (prospective).
format Online
Article
Text
id pubmed-9314866
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93148662022-07-30 Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial Webb, Ashley R Coward, Lisa Meanger, Darshana Leong, Samuel White, Sarah L Borland, Ron Med J Aust Research and Reviews OBJECTIVE: To assess whether offering free mailed nicotine replacement therapy (NRT) and telephone counselling to smokers on elective surgery waiting lists increases quitting before surgery. DESIGN, SETTING: Randomised, controlled trial at Frankston Hospital, a public tertiary referral hospital in Melbourne. PARTICIPANTS: Adult smokers added to elective surgery waiting lists for operations at least ten days in the future, 1 April 2019 ‒ 3 April 2020. INTERVENTION: In addition to normal care, intervention participants received a brochure on the risks of low frequency smoking, an offer of Quitline call‐back registration, and an offer of mailed NRT according to reported daily smoking: 1‒9 cigarettes/day, 2 mg lozenges; 10‒15/day, 7‒14 mg patches [three weeks] and 2 mg lozenges; > 15/day, 7‒21 mg patches [five weeks] and 2 mg lozenges. MAIN OUTCOME MEASURES: Primary outcome: quitting at least 24 hours before surgery, verified by exhaled carbon monoxide testing. Secondary outcomes: quitting at least four weeks before surgery, adverse events, and (for those who had quit before surgery) abstinence three months after surgery. RESULTS: Of 748 eligible participants (control, 363; intervention, 385), 516 (69%) had undergone elective surgery when the trial was terminated early (for COVID‐19‐related reasons) (intervention group, 274; control group, 242). 122 of the 385 intervention participants (32%) had accepted the offer of cessation support. The proportions of intervention participants who quit at least 24 hours before surgery (18% v 9%; odds ratio [OR], 1.97; 95% CI, 1.22‒3.15) or at least four weeks before surgery (9% v 4%; OR, 2.20; 95% CI, 1.08–4.50) were larger than for the control group. Three months after surgery, 27 of 58 intervention (47%) and 12 of 25 control participants (48%) who quit before surgery reported not smoking in the preceding seven days. No major adverse events were reported. CONCLUSION: Uptake of free mailed NRT and Quitline support by smokers on elective surgery waiting lists was good, and offering additional support was associated with higher proportions of smokers quitting before surgery. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12619000032156 (prospective). John Wiley and Sons Inc. 2022-03-10 2022-04 /pmc/articles/PMC9314866/ /pubmed/35267206 http://dx.doi.org/10.5694/mja2.51453 Text en © 2021 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research and Reviews
Webb, Ashley R
Coward, Lisa
Meanger, Darshana
Leong, Samuel
White, Sarah L
Borland, Ron
Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial
title Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial
title_full Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial
title_fullStr Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial
title_full_unstemmed Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial
title_short Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial
title_sort offering mailed nicotine replacement therapy and quitline support before elective surgery: a randomised controlled trial
topic Research and Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314866/
https://www.ncbi.nlm.nih.gov/pubmed/35267206
http://dx.doi.org/10.5694/mja2.51453
work_keys_str_mv AT webbashleyr offeringmailednicotinereplacementtherapyandquitlinesupportbeforeelectivesurgeryarandomisedcontrolledtrial
AT cowardlisa offeringmailednicotinereplacementtherapyandquitlinesupportbeforeelectivesurgeryarandomisedcontrolledtrial
AT meangerdarshana offeringmailednicotinereplacementtherapyandquitlinesupportbeforeelectivesurgeryarandomisedcontrolledtrial
AT leongsamuel offeringmailednicotinereplacementtherapyandquitlinesupportbeforeelectivesurgeryarandomisedcontrolledtrial
AT whitesarahl offeringmailednicotinereplacementtherapyandquitlinesupportbeforeelectivesurgeryarandomisedcontrolledtrial
AT borlandron offeringmailednicotinereplacementtherapyandquitlinesupportbeforeelectivesurgeryarandomisedcontrolledtrial